WILMINGTON, DE — Health technology company Diabetes Actual has announced a substantial royalty payment for all promotional license holders. On March 13th, 2024, the venture of MariamTek Inc., which focuses on diabetes treatment and cell health innovation, paid a royalty of $1 per license, causing a 250% spike in the license price, from $4 to $10.
Under the leadership of Dr. Mark Holterman, a distinguished physician-surgeon and research scientist, Diabetes Actual has made notable strides in diabetes care. The disease is one of the most taxing medical conditions in the U.S., presenting mounting challenges in patient care.
In response, Diabetes Actual has introduced a revenue-generating concept known as DiabetEASE Clinics. These clinics aim to reverse diabetes by restoring the natural rhythm of insulin release. This innovative approach not only mitigates the harmful effects of excessive insulin but also slows, and in some cases reverses, the progression of the disease.
The pilot clinic in the Chicago area has shown tangible success, offering a hopeful outlook for patients grappling with insulin resistance and related complications. Building on this success, Diabetes Actual plans to establish DiabetEASE Clinics in the U.S., United Arab Emirates, and India over the next two years.
To enable swift deployment of this groundbreaking therapy worldwide, Diabetes Actual has partnered with WellCell Global, based in Houston, TX, the discoverers and developers of the Physiologic Insulin Re-Sensitization clinical modality.
With an established clinic already generating revenue and regional and local licensing opportunities available, Diabetes Actual is poised for unprecedented growth. This move highlights the company’s determination to make its revolutionary diabetes treatment accessible to a wider audience, thereby amplifying its impact on global health.
The team at Diabetes Actual, led by Dr. Holterman, is dedicated to pushing the boundaries of medical science. They aim to offer a sustainable solution to combat diabetes and improve the quality of life for millions affected by this condition. As such, industry watchers will be keenly observing how these developments influence wider trends in diabetes treatment.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.